DRAFT-CASP: Distal Radius Acute Fracture Trial – Cast versus Splint; a randomised non-inferiority trial comparing clinical and cost-effectiveness of a standard care cast versus removable splint for adults with a distal radius fracture that does not require manipulation
In plain English
AI plain-English summaryEvery year, more than 100,000 people in the UK break their wrist, and the standard treatment—a heavy, non-removable plaster cast—may be overkill for fractures that do not need to be manually realigned. This matters because wearing a cast for weeks is inconvenient and can stiffen the wrist, yet doctors lack high-quality evidence that a cast is actually better than a simple removable splint for these common, stable fractures. The trial will directly compare the two approaches in terms of wrist function, pain, complications, and cost. If the removable splint proves as effective as the cast, it could become the new standard of care. That would mean patients can shower normally, remove the splint for gentle movement, and potentially return to daily activities sooner. It would also reduce the burden on fracture clinics, which currently spend time removing and reapplying casts, and lower NHS costs for materials and follow-up appointments. The trial’s economic evaluation will make the financial case explicit for health service commissioners.
View original technical description
View the original record at the funder ↗
Related Research
Grants with similar aims, by meaning.
Original classification
ResearchPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know